Psychometric evaluation of the PROMIS SD-SF-8b instrument in individuals experiencing vasomotor symptoms due to menopause by Neil M. Schultz, Antonia Morga, Emad Siddiqui, Stephanie E. Rhoten

Get full text

Pooled solifenacin overactive bladder trial data: Creation, validation and analysis of an integrated database by Christopher R. Chapple, Linda Cardozo, Robert Snijder, Emad Siddiqui, Sender Herschorn

Get full text

Qualitative study: burden of menopause-associated vasomotor symptoms (VMS) and validation of PROMIS Sleep Disturbance and Sleep-Related Impairment measures for assessment of VMS im... by Marci English, Boyka Stoykova, Christina Slota, Lynda Doward, Emad Siddiqui, Rebecca Crawford, Dana DiBenedetti

Get full text

Correction to: Qualitative study: burden of menopause-associated vasomotor symptoms (VMS) and validation of PROMIS sleep disturbance and sleep-related impairment measures for asses... by Marci English, Boyka Stoykova, Christina Slota, Lynda Doward, Emad Siddiqui, Rebecca Crawford, Dana DiBenedetti

Get full text

The efficacy and safety of mirabegron compared with solifenacin in overactive bladder patients dissatisfied with previous antimuscarinic treatment due to lack of efficacy: results... by Jose E. Batista, Heinz Kölbl, Sender Herschorn, Tomasz Rechberger, Javier Cambronero, Michael Halaska, Alex Coppell, Mathilde Kaper, Moses Huang, Emad Siddiqui

Get full text

Efficacy and safety of daily mirabegron 50 mg in male patients with overactive bladder: a critical analysis of five phase III studies by Andrea Tubaro, José E. Batista, Victor W. Nitti, Sender Herschorn, Christopher R. Chapple, Mary Beth Blauwet, Emad Siddiqui, Moses Huang, Matthias Oelke

Get full text